Showing results (51-60 of 224) with videos related to
Sort By:
Pageof 23
Alimentary Pharmacology & Therapeutics|April 1, 1997
Review article: COX-II inhibitors--a new generation of safer NSAIDs?M T Donnelly, C J HawkeyDrugs|August 1, 1989
Immunosuppressive drugs in inflammatory bowel disease. A review of their mechanisms of efficacy and place in therapyA B Hawthorne, C J HawkeyDigestive Diseases (Basel, Switzerland)|January 1, 1989
Aspirin and gastroduodenal injuryP J Prichard, C J HawkeyCurrent Pharmaceutical Design|October 8, 2003
Dual COX inhibition and upper gastrointestinal damageM M Skelly, C J HawkeyCurrent Pharmaceutical Design|April 12, 2002
Gastrointestinal safety of selective COX-2 inhibitorsC J Hawkey, M M SkellyProstaglandins, Leukotrienes, and Medicine|April 1, 1983
Benoxaprofen in the treatment of active ulcerative colitisC J Hawkey, D S RamptonLancet (London, England)|November 8, 1986
Prostaglandins for peptic ulcer: a promise unfulfilledC J Hawkey, R P WaltPostgraduate Medical Journal|January 1, 1989
Fatal theophylline toxicity precipitated by in situ pulmonary artery thrombosisR J Davies, C J HawkeyBritish Journal of Hospital Medicine|April 5, 1992
New treatments in inflammatory bowel diseaseA T Cole, C J HawkeyApoptosis : an International Journal on Programmed Cell Death|November 25, 2003
NSAIDs and the GI tract-potential hazards and benefitsL M Jackson, C J HawkeyPageof 23